LH Labcorp Holdings Inc. logo

LH Labcorp Holdings Inc.

Healthcare
$259.93+1.63%ClosedMarket Cap: $21.31B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

24.68

PEG

1.41

P/B

2.45

P/S

1.51

EV/EBITDA

13.29

DCF Value

$380.02

FCF Yield

6.5%

Div Yield

1.1%

Margins & Returns

Gross Margin

27.8%

Operating Margin

11.0%

Net Margin

6.7%

ROE

10.9%

ROA

4.9%

ROIC

7.5%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$3.54B$277.8M$
Q4 null$3.52B$164.7M$
FY null$13.95B$876.5M$
Q3 null$3.56B$261.1M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$311.33

Target (Median)

$300.00

Target Range

$300.00 - $334.00

3 Strong Buy12 Buy5 Hold0 Sell0 Strong Sell
Evercore ISI GroupOutperform
2026-04-08
Piper SandlerNeutral
2026-02-24
BairdOutperform
2026-02-18
JP MorganOverweight
2026-02-18
JP MorganOverweight
2025-11-07

Trading Activity

Insider Trades

View All
Schechter Adam Hdirector, officer: President & CEO
SellWed May 13
Schroeder Mark Sofficer: EVP, Pres Diagnostics & COO
SellMon Mar 30
Schroeder Mark Sofficer: EVP, Pres Diagnostics & COO
SellMon Mar 30
Schroeder Mark Sofficer: EVP, Pres Diagnostics & COO
SellMon Mar 30
Schroeder Mark Sofficer: EVP, Pres Diagnostics & COO
SellMon Mar 30

Company Info

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

US

Exchange

Beta

0.88

Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

Peers